Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing.

Together, Bridgette and Hassan explore:

1. The expansion and evolution of the Medicare Drug Price Negotiation Program
2. Court challenges to the Negotiation Program
3. Drug pricing reform and the OBBBA
4. Impacts on patients and hospitals related to Medicare Part D, 340B, and OPPS clawbacks
5. The rise of direct-to-consumer drug sales models

Bridgette and Hassan cut through the complexity and provide an overview of these topics, which are covered in greater depth in the Q3 2025 Edition of the Mintz IRA Update.